Web11 dec. 2024 · IDEAYA Biosciences is an oncology specialist focused on precision medicine aiming to utilize molecular diagnostics to develop targeted therapeutics with a research … WebIDEAYA Biosciences (NASDAQ: IDYA) is a public, clinical-stage synthetic lethality-focused precision medicine oncology company committed to the discovery and development of …

IDEAYA Biosciences Announces Closing of Initial Public ... - BioSpace

WebImproving Lives through Transformative Precision Medicines IDEAYA is a clinical-stage precision medicine oncology company. Our teams are committed to the discovery and … From 2005-2016, Dr. Sellers directed cancer drug discovery and early cancer … IDEAYA’s translational biology platform is based on cutting-edge technologies for … IDEAYA is pursuing precision medicine therapeutics, with a broad pipeline … IDEAYA Announces First-Patient-In for Phase I Clinical Trial to Evaluate … IDEAYA is a precision medicine oncology company committed to the discovery … IDEAYA Biosciences is an equal opportunity employer and will not … 7000 Shoreline Court, Suite 350 South San Francisco, CA 94080. 10996 Torreyana … SOUTH SAN FRANCISCO, Calif., Sept. 14, 2024 /PRNewswire/ -- IDEAYA … WebDr. Axel Hoos is CEO of Scorpion Therapeutics, a Boston-based Biotechnology company focused on Precision Oncology 2.0 to optimize … milb wilmington

IDEAYA Announces Presentations at AACR Annual Meeting 2024 …

WebIDE397 is a novel MAT2A inhibitor being evaluated in cancer patients harboring a tumor having MTAP deletion. IDE397 has superior cellular potency, selectivity, and drug … Web13 jan. 2024 · IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient … WebRepare Therapeutics is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to developing novel medicines. milby actor